| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 0 | 0 | 0 | 0 | 12.354 | 23.925 | 31.927 | 37.560 | 38.828 | 30.446 |
| Total Income - EUR | 0 | 0 | 0 | 0 | 12.354 | 23.925 | 31.927 | 37.560 | 40.058 | 30.493 |
| Total Expenses - EUR | 0 | 0 | 566 | 0 | 1.331 | 2.914 | 3.087 | 4.553 | 21.383 | 27.095 |
| Gross Profit/Loss - EUR | 0 | 0 | -566 | 0 | 11.023 | 21.011 | 28.840 | 33.007 | 18.675 | 3.397 |
| Net Profit/Loss - EUR | 0 | 0 | -566 | 0 | 10.652 | 20.346 | 27.997 | 32.183 | 18.282 | 2.502 |
| Employees | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 1 |
Check the financial reports for the company - Ayus Medicine Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 668 | 661 | 650 | 638 | 625 | 614 | 600 | 602 | 19.757 | 14.520 |
| Current Assets | 238 | 236 | 232 | 228 | 1.555 | 18.696 | 30.084 | 33.021 | 17.647 | 8.603 |
| Inventories | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | 238 | 235 | 231 | 227 | 183 | 8.616 | 16.637 | 14.138 | 7.281 | 3.168 |
| Cash | 1 | 1 | 1 | 1 | 1.372 | 10.080 | 13.447 | 18.883 | 10.367 | 5.435 |
| Shareholders Funds | -13.291 | -13.155 | -13.499 | -13.251 | -2.342 | 18.048 | 29.473 | 32.224 | 19.564 | 2.542 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 14.350 | 14.204 | 14.529 | 14.263 | 4.666 | 1.419 | 1.348 | 1.541 | 18.471 | 20.780 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Ayus Medicine Srl